Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dermatologists in Spain now mostly prescribe oral minoxidil and dutasteride for hair loss.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.

Trichoscopy is effective in diagnosing trichotillomania by showing specific hair patterns.

A woman's excess male hormone symptoms were caused by a rare benign tumor in her ovary.

Lupus and frontal fibrosing alopecia may share a common cause.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Including androgens in hormone therapy may lower breast cancer risk.

Lichen planopilaris is more common in older women and may be linked to hormone therapy and autoimmune diseases.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Collagen supplements may improve skin, hair, and nails, but more research is needed.

Ancient hair can preserve hormones, revealing health and fertility insights.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Young coconut juice speeds up wound healing.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.